Dopaminergic brain system in the quaking mutant mouse

Ella M Nikulina, Julia A. Skrinskaya, Damira F. Avgustinovich, Nina K. Popova

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Quaking mice ( qk qk), autosomal recessive mutants with central nervous system dysmyelinization, characterized behaviorally by abnormal locomotion and tremor, are found to have altered brain dopaminergic system parameters, in comparison with phenotypically normal heterozygous littermates. Dopamine metabolism is enhanced in structures of both nigrostriatal and mesolimbic systems, as revealed by increased metabolites content (that of homovanillic acid in striatum and concentration of 3,4-dihydroxyphenylacetic acid in nucleus accumbens with tuberculum olfactorium) along with unchanged neurotransmitter levels in qk qk mice. D1 and D2 receptor analysis via radioligand binding using [3H]-SCH 23390 and [3H]-spiperone, correspondingly, showed an increase of D2 receptor density with decreased affinity to D2 ligand in striatum of mutants: both Bmax and Kd were markedly higher. D1 and D2 receptor sensitivity in the quaking mouse was also altered. Stimulation of D1 receptors by a highly specific agonist SKF 38393 (2.5 and 5 mg/kg) decreased locomotor activity only in mutants, but not in controls. In contrast, qk qk were less sensitive than phenotypically normal qk/+ mice to a selective D2 dopamine receptor agonist, LY 171555 (quinpirole, 1 and 2.5 mg/kg). The alterations found in the brain dopaminergic system of qk qk mice may be responsible for the behavioral expression of this neurologic mutation.

Original languageEnglish (US)
Pages (from-to)333-337
Number of pages5
JournalPharmacology, Biochemistry and Behavior
Volume50
Issue number3
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Quaking Mice
Brain
Locomotion
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Quinpirole
Spiperone
3,4-Dihydroxyphenylacetic Acid
Homovanillic Acid
Dopamine Agonists
Neurology
4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrzolo(3,4-g)quinoline
Metabolites
Metabolism
Neurotransmitter Agents
Dopamine
Nucleus Accumbens
Tremor
Ligands
Nervous System
Central Nervous System

Keywords

  • D and D dopamine receptor agonists
  • D and D receptor binding
  • Dopamine metabolism
  • Locomotor activity
  • Quaking mutation

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Pharmacology
  • Toxicology

Cite this

Dopaminergic brain system in the quaking mutant mouse. / Nikulina, Ella M; Skrinskaya, Julia A.; Avgustinovich, Damira F.; Popova, Nina K.

In: Pharmacology, Biochemistry and Behavior, Vol. 50, No. 3, 1995, p. 333-337.

Research output: Contribution to journalArticle

Nikulina, Ella M ; Skrinskaya, Julia A. ; Avgustinovich, Damira F. ; Popova, Nina K. / Dopaminergic brain system in the quaking mutant mouse. In: Pharmacology, Biochemistry and Behavior. 1995 ; Vol. 50, No. 3. pp. 333-337.
@article{25cf0081dcdb440296fd86045068036c,
title = "Dopaminergic brain system in the quaking mutant mouse",
abstract = "Quaking mice ( qk qk), autosomal recessive mutants with central nervous system dysmyelinization, characterized behaviorally by abnormal locomotion and tremor, are found to have altered brain dopaminergic system parameters, in comparison with phenotypically normal heterozygous littermates. Dopamine metabolism is enhanced in structures of both nigrostriatal and mesolimbic systems, as revealed by increased metabolites content (that of homovanillic acid in striatum and concentration of 3,4-dihydroxyphenylacetic acid in nucleus accumbens with tuberculum olfactorium) along with unchanged neurotransmitter levels in qk qk mice. D1 and D2 receptor analysis via radioligand binding using [3H]-SCH 23390 and [3H]-spiperone, correspondingly, showed an increase of D2 receptor density with decreased affinity to D2 ligand in striatum of mutants: both Bmax and Kd were markedly higher. D1 and D2 receptor sensitivity in the quaking mouse was also altered. Stimulation of D1 receptors by a highly specific agonist SKF 38393 (2.5 and 5 mg/kg) decreased locomotor activity only in mutants, but not in controls. In contrast, qk qk were less sensitive than phenotypically normal qk/+ mice to a selective D2 dopamine receptor agonist, LY 171555 (quinpirole, 1 and 2.5 mg/kg). The alterations found in the brain dopaminergic system of qk qk mice may be responsible for the behavioral expression of this neurologic mutation.",
keywords = "D and D dopamine receptor agonists, D and D receptor binding, Dopamine metabolism, Locomotor activity, Quaking mutation",
author = "Nikulina, {Ella M} and Skrinskaya, {Julia A.} and Avgustinovich, {Damira F.} and Popova, {Nina K.}",
year = "1995",
doi = "10.1016/0091-3057(94)00267-M",
language = "English (US)",
volume = "50",
pages = "333--337",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Dopaminergic brain system in the quaking mutant mouse

AU - Nikulina, Ella M

AU - Skrinskaya, Julia A.

AU - Avgustinovich, Damira F.

AU - Popova, Nina K.

PY - 1995

Y1 - 1995

N2 - Quaking mice ( qk qk), autosomal recessive mutants with central nervous system dysmyelinization, characterized behaviorally by abnormal locomotion and tremor, are found to have altered brain dopaminergic system parameters, in comparison with phenotypically normal heterozygous littermates. Dopamine metabolism is enhanced in structures of both nigrostriatal and mesolimbic systems, as revealed by increased metabolites content (that of homovanillic acid in striatum and concentration of 3,4-dihydroxyphenylacetic acid in nucleus accumbens with tuberculum olfactorium) along with unchanged neurotransmitter levels in qk qk mice. D1 and D2 receptor analysis via radioligand binding using [3H]-SCH 23390 and [3H]-spiperone, correspondingly, showed an increase of D2 receptor density with decreased affinity to D2 ligand in striatum of mutants: both Bmax and Kd were markedly higher. D1 and D2 receptor sensitivity in the quaking mouse was also altered. Stimulation of D1 receptors by a highly specific agonist SKF 38393 (2.5 and 5 mg/kg) decreased locomotor activity only in mutants, but not in controls. In contrast, qk qk were less sensitive than phenotypically normal qk/+ mice to a selective D2 dopamine receptor agonist, LY 171555 (quinpirole, 1 and 2.5 mg/kg). The alterations found in the brain dopaminergic system of qk qk mice may be responsible for the behavioral expression of this neurologic mutation.

AB - Quaking mice ( qk qk), autosomal recessive mutants with central nervous system dysmyelinization, characterized behaviorally by abnormal locomotion and tremor, are found to have altered brain dopaminergic system parameters, in comparison with phenotypically normal heterozygous littermates. Dopamine metabolism is enhanced in structures of both nigrostriatal and mesolimbic systems, as revealed by increased metabolites content (that of homovanillic acid in striatum and concentration of 3,4-dihydroxyphenylacetic acid in nucleus accumbens with tuberculum olfactorium) along with unchanged neurotransmitter levels in qk qk mice. D1 and D2 receptor analysis via radioligand binding using [3H]-SCH 23390 and [3H]-spiperone, correspondingly, showed an increase of D2 receptor density with decreased affinity to D2 ligand in striatum of mutants: both Bmax and Kd were markedly higher. D1 and D2 receptor sensitivity in the quaking mouse was also altered. Stimulation of D1 receptors by a highly specific agonist SKF 38393 (2.5 and 5 mg/kg) decreased locomotor activity only in mutants, but not in controls. In contrast, qk qk were less sensitive than phenotypically normal qk/+ mice to a selective D2 dopamine receptor agonist, LY 171555 (quinpirole, 1 and 2.5 mg/kg). The alterations found in the brain dopaminergic system of qk qk mice may be responsible for the behavioral expression of this neurologic mutation.

KW - D and D dopamine receptor agonists

KW - D and D receptor binding

KW - Dopamine metabolism

KW - Locomotor activity

KW - Quaking mutation

UR - http://www.scopus.com/inward/record.url?scp=0028916789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028916789&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(94)00267-M

DO - 10.1016/0091-3057(94)00267-M

M3 - Article

C2 - 7617670

AN - SCOPUS:0028916789

VL - 50

SP - 333

EP - 337

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 3

ER -